Kakaretso ea Dopamine Receptor Mosebetsi Nucleus Accumbens Shell e phahamisa ho tšoenyeha ha nakong ea lithethefatsi ho tlosoa (2012)

Neuropsychopharmacology. 2012 Jun 13. Doi: 10.1038 / npp.2012.97.

Radke AK, Gewirtz JC.

mohloli o moholo

Lenaneo la Boikarabello Neuroscience, Minneapolis, MN, USA.

inahaneloang

Mabaka a 'maloa a bopaki a bontša hore matšoao a mabe a maikutlo a ho tlohela a kenyelletsa ts'ebetso e fokotsehileng tsamaisong ea mesolimbic dopamine. Phuputso ena e ile ea lekola tlatsetso ea lets'oao la dopaminergic mohahong o ka tlase ho sebaka sa karolelano ea moea hore o tlohe pontšong ea moriana oa morphine, o lekantsoeng joalo ka bokhoni ba makhopho a hlohlontšang mahlo. Tsamaiso ea tsamaiso ea "dopamine receptor agonist apomistphine" e tloaelehileng ea "receptor agonist" e joalo ka "" receptor agonist ". Phello ena e ile ea phetoa ke ho kenella ha apomorphine ka har'a khetla ea nucleus ea bokellase. Kamora nako, ente ea apomorphine e ile ea bontšoa ho fokotsa tšabo nakong ea ha a khaotsa ho tsuba 'me a beha maemo ho hanyetsa morphine. Liphetho tsena li fana ka maikutlo a hore ts'ebetso ea nakoana ea ts'ebetso ea "ventral tegmental area mesolimbic dopamine system" e etsa hore ho be le pherekano le ho ferekana nakong ea ho tlohela litsi tse fapaneng tsa litlhare tse hlekefelitsoeng.